Serum Golimumab Exposure and the Incidence of Selected Safety Events in Patients With Ulcerative Colitis Following Treatment With Golimumab: An Exploratory Analysis of the PURSUIT Study Data

被引：0
|
作者：
Adedokun, Omoniyi J.
Xu, Zhenhua
Marano, Colleen W.
Strauss, Richard
Zhang, Hongyan
Johanns, Jewel
Zhou, Honghui
Davis, Hugh M.
Liao, Sam
Colombel, Jean-Frederic
Reinisch, Walter
Feagan, Brian G.
Rutgeerts, Paul J.
Gibson, Peter R.
Sandborn, William
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1215
引用
收藏
页码：S588 / S588
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of golimumab in patients with ulcerative colitis: a prospective multicentre study
    Varvara, D.
    Costantino, G.
    Privitera, A. C.
    Principi, B.
    Cappello, M.
    Mazzuoli, S.
    Paiano, P.
    Tursi, A.
    Paese, P.
    Fries, W.
    Andriulli, A.
    Bossa, F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S279 - S280
  • [2] Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
    Yu, Jongwook
    Park, Soo Jung
    Kim, Hyung Wook
    Lim, Yun Jeong
    Park, Jihye
    Cha, Jae Myung
    Ye, Byong Duk
    Kim, Tae Oh
    Kim, Hyun-Soo
    Lee, Hyun Seok
    Jung, Su Young
    Kim, Youngdoe
    Choi, Chang Hwan
    GUT AND LIVER, 2022, 16 (05) : 764 - 774
  • [3] Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland
    Perrig, K.
    Rossel, J. -B.
    Biedermann, L.
    Schreiner, P.
    Roth, R.
    Zeitz, J.
    Greuter, T.
    Vavricka, S.
    Krupka, N.
    Juillerat, P.
    Rogler, G.
    Misselwitz, B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S278 - S278
  • [4] Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study
    Bossa, F.
    Valvano, M. R.
    Costantino, G.
    Vinci, E.
    Rispo, A.
    Mendolaro, M.
    Patturelli, M.
    Shaini, E.
    Mazzuoli, S.
    RIcciardelli, C.
    Tursi, A.
    Lauria, A.
    Paese, P.
    Azzarone, A.
    Sebkova, L.
    Pranzo, G.
    Fries, W.
    Castiglione, F.
    Cappello, M.
    Privitera, A.
    Principi, B.
    Andriulli, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S397 - S398
  • [5] Comparative Efficacy of Adalimumab, Golimumab, and Infliximab in the Treatment of Patients with Ulcerative Colitis: An Induction Analysis
    Mallow, Peter
    Rizzo, John
    Queener, MaryKay
    Gathany, Timothy
    Lofland, Jennifer
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S514 - S514
  • [6] Efficacy of golimumab for the treatment of ulcerative colitis patients in clinical practice: a retrospective cohort study
    Dufour, G.
    Altwegg, R.
    Valats, J. -C.
    Bismuth, M.
    Funakoshi, N.
    Gonzalez, F.
    Caillo, L.
    Pouderoux, P.
    Blanc, P.
    de Chambrun, G. Pineton
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S259 - S259
  • [7] Predictors of treatment persistence in ulcerative colitis patients treated with golimumab: A multicentre cohort study
    Biscaglia, G.
    Savarino, E.
    Variola, A.
    Furfaro, F.
    Ferracane, C.
    Rizzati, G.
    Scaldaferri, F.
    Mocci, G.
    Buda, A.
    Privitera, A.
    Geccherle, A.
    Fiorino, G.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S419 - S419
  • [8] Characterization of patients with ulcerative colitis in a postauthorization safety study of golimumab based in the Spanish ENEIDA registry
    Fortuny, Joan
    Rasouliyan, Lawrence
    Mines, Daniel
    Tormos, Anita
    Earley, Elizabeth
    Perez-Gutthann, Susana
    Domenech, Eugeni
    Gisbert, Javier P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 47 - 47
  • [9] Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension
    Reinisch, Walter
    Gibson, Peter R.
    Sandborn, William
    Feagan, Brian G.
    Marano, Colleen
    Strauss, Rick
    Johanns, Jewel
    Zhang, Hongyan
    Padgett, Lakshmi
    Adedokun, Omoniyi J.
    Colombel, Jean-Frederic
    Collins, Judith
    Rutgeerts, Paul J.
    Tarabar, Dino
    GASTROENTEROLOGY, 2016, 150 (04) : S776 - S777
  • [10] Safety, efficacy, and pharmacokinetics of golimumab in patients with moderately to severely Active ulcerative colitis: PURSUIT-SC long-term extension
    Reinisch, W.
    Gibson, P.
    Sandborn, W. J.
    Feagan, B.
    Marano, C.
    Strauss, R.
    Johanns, J.
    Zhang, H.
    Padgett, L.
    Adedokun, O. J.
    Colombel, J. -F.
    Collins, J.
    Rutgeerts, P.
    Tarabar, D.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S248 - S249
12345